Venus Concept Inc. announced that it has received a 510(k) clearance from the U.S. Food and Drug Administration (?FDA?) to market its Venus Versa Pro System, the Company?s new multi-application platform, for a variety of aesthetic and cosmetic procedures. Venus Versa is a modular system based on a multi-application approach. It is customizable and upgradable and offers the most in-demand aesthetic treatments by supporting 10 optional applicators which utilize Venus Concept?s (MP)2, IPL and NanoFractional RF technologies.

Designed as a modular platform, the Venus Versa can be configured to best suit any practice?s needs with the ability to add additional applications as the practice grows or changes. The all new Venus Versa Pro System expands on the already comprehensive Venus Versa platform by incorporating proprietary advances in NanoFractional RF technologies from its dedicated skin resurfacing system, Venus VivaMD, providing higher power and deeper skin penetration for optimal results.